Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Martin Marietta Materials
MLM
$37.5B
| $2.48M | ﹤0.01% |
14,426
+8,785
| +156% | +$1.56M |
|
2052
Enpro
NPO
$6.53B
| $2.47M | ﹤0.01% |
41,163
-90,505
| -69% | -$6M |
|
2053
State Street Energy Select Sector SPDR ETF
XLE
$40.9B
| $2.47M | ﹤0.01% |
86,000
-17,368
| -17% | -$581K |
|
2054
Kinross Gold
KGC
$38.6B
| $2.46M | ﹤0.01% |
758,869
-1,770,268
| -70% | -$4.95M |
|
|
SAIL
2055
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.45M | ﹤0.01% |
104,235
-608,202
| -85% | -$15.6M |
|
2056
NIO
NIO
$10.9B
| $2.45M | ﹤0.01% |
384,000
-1,786,568
| -82% | -$12.4M |
|
|
PVLA
2057
Palvella Therapeutics
PVLA
$2.17B
| $2.45M | ﹤0.01% |
11,495
-9,797
| -46% | -$3.04M |
|
|
MYOK
2058
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.44M | ﹤0.01% |
50,036
-148,442
| -75% | -$8.17M |
|
2059
PUT
Mattel
MAT
$4.26B
| $2.44M | ﹤0.01% |
+244,600
| New | +$3.24M |
|
2060
Navient
NAVI
$873M
| $2.44M | ﹤0.01% |
276,995
-44,730
| -14% | -$513K |
|
|
REN
2061
DELISTED
Resolute Energy Corporaton
REN
| $2.44M | ﹤0.01% |
+84,181
| New | +$2.66M |
|
|
AGEN
2062
Agenus
AGEN
$352M
| $2.43M | ﹤0.01% |
52,040
+19,277
| +59% | +$804K |
|
2063
Cenovus Energy
CVE
$58.5B
| $2.43M | ﹤0.01% |
+345,318
| New | +$2.84M |
|
2064
Horace Mann Educators
HMN
$2.07B
| $2.43M | ﹤0.01% |
64,770
-207,490
| -76% | -$8.21M |
|
2065
Cato Corp
CATO
$53.1M
| $2.42M | ﹤0.01% |
169,872
+87,669
| +107% | +$1.51M |
|
2066
AdvanSix
ASIX
$442M
| $2.42M | ﹤0.01% |
99,401
-31,519
| -24% | -$875K |
|
|
SINA
2067
DELISTED
Sina Corp
SINA
| $2.42M | ﹤0.01% |
45,106
+40,581
| +897% | +$2.51M |
|
|
ECHO
2068
DELISTED
Echo Global Logistics, Inc.
ECHO
| $2.42M | ﹤0.01% |
118,955
-31,332
| -21% | -$781K |
|
|
NFX
2069
DELISTED
Newfield Exploration
NFX
| $2.4M | ﹤0.01% |
163,592
-1,857,245
| -92% | -$37.4M |
|
2070
CALL
DexCom
DXCM
$33.7B
| $2.4M | ﹤0.01% |
80,000
-120,000
| -60% | -$3.81M |
|
|
2071
PUT
DexCom
DXCM
$33.7B
| $2.4M | ﹤0.01% |
80,000
+40,000
| +100% | +$1.27M |
|
2072
Healthcare Services Group
HCSG
$1.57B
| $2.4M | ﹤0.01% |
59,617
+43,252
| +264% | +$1.83M |
|
|
XENT
2073
CALL
DELISTED
Intersect ENT, Inc
XENT
| $2.4M | ﹤0.01% |
85,000
-45,000
| -35% | -$1.32M |
|
2074
Marriott Vacations Worldwide
VAC
$3.83B
| $2.39M | ﹤0.01% |
33,948
-631,862
| -95% | -$52.6M |
|
2075
CytomX Therapeutics
CTMX
$745M
| $2.39M | ﹤0.01% |
158,438
-59,053
| -27% | -$876K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.